Related Experiment Video
Updated: Sep 22, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Saprochaete clavata Chorioretinitis in a Post-chemotherapy Immunocompromised 9-Year-Old Child
Paul Goupillou1, Damien Costa2,3, Gilles Gargala2,3
1Department of Ophthalmology, Rouen University Hospital, Rouen, France.
Insights
This case report details managing bilateral chorioretinitis caused by Saprochaete clavata in a child with acute myeloid leukemia. Intravitreal voriconazole and amphotericin B were crucial for successful treatment and vision recovery.
Area of Science:
- Ophthalmology
- Mycology
- Pediatric Oncology
Background:
- Bilateral chorioretinitis is a severe ocular condition.
- Saprochaete clavata is an opportunistic fungal pathogen.
- Immunocompromised patients, particularly those undergoing chemotherapy, are at high risk for invasive fungal infections.
Observation:
- A 9-year-old boy with acute myeloid leukemia developed fungemia due to Saprochaete clavata.
- Ocular examination revealed progressive bilateral chorioretinitis.
- Initial systemic treatment with voriconazole, amphotericin B, and flucytosine was insufficient.
Findings:
- Bilateral intravitreal amphotericin B injections were administered.
- Voriconazole blood concentrations were monitored and adjusted.
- Visual acuity improved to 20/50 in the right eye and 20/20 in the left eye.
Implications:
- This is the first reported case of chorioretinitis caused by Saprochaete clavata.
- Therapeutic drug monitoring of voriconazole is essential in pediatric patients due to unpredictable pharmacokinetics.
- Aggressive management including intravitreal therapy may be necessary for sight-threatening fungal endophthalmitis.
Purpose:
To describe the management of bilateral chorioretinitis with Saprochaete clavata in a post-chemotherapy immunocompromised young patient.
Method:
A retrospective case report.
Result:
A 9-year-old boy treated with chemotherapy for type 2 acute myeloid leukaemia was diagnosed with Saprochaete clavata (formerly called Geotrichum clavatum) fungaemia. Systematic ocular examination revealed chorioretinitis of the left eye becoming bilateral within the next 3 days. Therapy was based on systemic administration of voriconazole, amphotericin B and flucytosine associated with granulocytic stimulation without stabilizing the ophthalmological situation. Bilateral intravitreal injections of amphotericin B were administered. Voriconazole residual blood concentration was monitored to adjust daily dose. Final best corrected visual acuity in the right eye was 20/50 and 20/20 in the left eye.
Conclusion:
This is the first report of chorioretinitis with Saprochaete clavata. Because of its unpredictable pharmacokinetics, especially in pediatric population, therapeutic drug monitoring of voriconazole is essential to control fungal infection.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

